ICYMI: A Summary of Annual Meeting 2019 Blog Posts
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum to present and discuss the latest breakthroughs in cutting-edge basic, translational, and clinical cancer research. As always, the meeting attracted the leading minds in research and medicine, representing many facets of cancer research and care. Researchers, physician-scientists, policymakers, patients, advocates, and industry representatives all played important roles in exchanging information over the course of a dynamic Annual Meeting program.
The staff of Cancer Research Catalyst covered the meeting extensively, beginning in early February, when we introduced readers to Program Chair John D. Carpten, PhD. While researchers around the world polished their presentations and meeting staffers worked to ensure that the Georgia World Congress Center in Atlanta was ready, we published posts that took readers behind the scenes and highlighted some of the research that would be shared during the meeting. In case you missed it, here’s a look at our pre-meeting coverage:
Meet John D. Carpten, PhD, Program Chair of the AACR Annual Meeting 2019
Behind the Scenes at the Annual Meeting: Five Questions With the AACR’s Senior Director of Meetings
Media Gets Sneak Peek at Annual Meeting Scientific Presentations
The Poster Sessions: Showcasing the Latest Research
Women in Cancer Research Group Celebrates 20 Years
Prostate Cancer Disparities: Race-related Biological Differences
Enabling Promising Postdocs to Become the Global Research Leaders of Tomorrow
The meeting kicks off
The Annual Meeting began shortly after the National Cancer Institute, the federal government’s principal agency for research and training, announced a change in leadership. The AACR was thrilled to welcome both the outgoing and the incoming directors of the NCI to the Opening Ceremony of the meeting. A post featuring remarks by Norman “Ned” Sharpless, MD, FAACR, and Douglas R. Lowy, MD, FAACR, kicked off a wave of coverage during the meeting:
AACR Annual Meeting 2019: NCI Leaders Praise Progress and Collaboration
AACR Annual Meeting 2019: The Biden Cancer Initiative
AACR Annual Meeting 2019: Preclinical Steps Toward a Cancer Preventive Vaccine for Lynch Syndrome
AACR Annual Meeting 2019: Plenary Examines Global Issues in Cancer
AACR Annual Meeting 2019: Recent Progress for Patients With Hard-to-treat and Rare Cancers
AACR Annual Meeting 2019: Promising Data from CAR T-cell Clinical Trials for Advanced Solid Tumors
AACR Annual Meeting 2019: Manipulating the Immune System in Cancer Therapy
AACR Annual Meeting 2019: Global Burden of Pathogen-related Cancers
AACR Annual Meeting 2019: Optimizing PD-1/PD-L1 Immune Checkpoint Inhibitor Therapy
Continuing coverage of Annual Meeting 2019
Once the meeting drew to a close, we continued to write about some of the exciting research presented in various plenary sessions and symposia. Meeting attendees have given us a treasure trove of research to feature in the coming months, so please keep reading. And if you’d like to contribute a guest post based on your own meeting experience, please see our contributors’ guidelines. Here are the posts we’ve published since the Annual Meeting concluded:
AACR Annual Meeting 2019: PD-1 Pandemonium
AACR Annual Meeting 2019: New Approaches to Treating Drug-resistant Non-small Cell Lung Cancer
AACR Annual Meeting 2019: Patients as Partners in the Research Process
AACR Annual Meeting 2019: A Record Year for Clinical Trials Presentations
AACR Annual Meeting 2019: Past, Present, and Future of CDK4/6-targeted Therapeutics
AACR Annual Meeting 2019: Leaders Share Highlights and Future Direction
